Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.315
-0.005 (-0.22%)
Apr 29, 2026, 9:50 AM EDT - Market open
Galectin Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -30.84 | -47.05 | -41.07 | -38.78 | -30.53 | |
| Depreciation & Amortization | 0.05 | 0.04 | 0.03 | 0.03 | 0.04 | |
| Stock-Based Compensation | 1.66 | 2.45 | 2.26 | 2.87 | 2.08 | |
| Other Operating Activities | 4.64 | 0.51 | 1.13 | -0.15 | 0.15 | |
| Change in Accounts Payable | -6.04 | -2.07 | 2.67 | 4.24 | 3.69 | |
| Change in Other Net Operating Assets | 6.65 | 4.36 | 2.01 | 0.72 | 0.27 | |
| Operating Cash Flow | -23.88 | -41.77 | -32.97 | -31.06 | -24.31 | |
| Long-Term Debt Issued | 21 | 30 | 30 | 10 | 30 | |
| Net Debt Issued (Repaid) | 21 | 30 | 30 | 10 | 30 | |
| Issuance of Common Stock | 5.48 | 1.23 | 10.03 | - | 6.81 | |
| Financing Cash Flow | 26.48 | 31.23 | 40.03 | 10 | 36.81 | |
| Net Cash Flow | 2.6 | -10.54 | 7.07 | -21.06 | 12.51 | |
| Levered Free Cash Flow | -20.9 | -29.31 | -20.68 | -17.56 | -13.23 | |
| Unlevered Free Cash Flow | -16.32 | -25.84 | -18.93 | -16.91 | -12.92 | |
| Change in Working Capital | 0.61 | 2.28 | 4.68 | 4.97 | 3.96 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.